Abstract:abstract: It is becoming more and harder in today's climate to disregard the impact of cancer on social health. Even though a significant amount of money is spent annually on cancer research, it still ranks as the second leading cause of death worldwide. Additionally, only about half of the patients suffering from complex forms of cancer survive a year after receiving traditional cancer therapies. A method for silencing genes is called RNA interference (RNAi). Such a method is very effective in focusing on genes linked to cancer. Most gene products implicated in cancer have recently been used as RNA interference (RNAi) therapeutic targets. According to the findings from this research, RNAi application is necessary for today's cancer treatment to target functioning carcinogenic molecules and tumor resistance to chemotherapy and radiation. Proapoptotic and antiproliferative activity has been reported from previous research studies on cell culture systems, animal models, and clinical trials through the knockdown of gene products from RNAi technology. Numerous novel RNAi-based medications are now in the clinical trial stages thanks to the discovery of the RNAi mechanism and advancements in the area. In the future, genomic-based personalized medicines can be developed through this RNAi therapy. Hopefully, cancer sufferers will find this sort of therapy to be one of the most effective ones. Various kinds of RNA-based treatments, such as aptamers, small interfering RNAs, microRNAs, antisense oligonucleotides, and messenger RNA, are covered in broad terms in this study. We also present an overview of the RNA-based therapies that have received regulatory approval in the past or are now undergoing clinical studies.

Progress of RNA interfere in gene therapy for oral tumor

RNA interference mediated by oncolytic viruses in tumor therapy

RNA interference and tumor gene therapy

RNA Cancer Nanomedicine: Nanotechnology-Mediated RNA Therapy.

A novel strategy for cancer gene therapy: RNAi

Recent Advances in RNA-Targeted Cancer Therapy

The Application of the RNA Interference Technology in the Gene Therapy

Advance in Gene Therapy of Tumors

Nano-based delivery of RNAi in cancer therapy

Oral delivery of RNAi for cancer therapy

Insight Into the Prospects for RNAi Therapy of Cancer

Therapeutic Potentials of Gene Silencing by RNA Interference: Principles, Challenges, and New Strategies.

Advancement and prospects of tumor gene therapy

RNA-based Therapeutics: an Overview and Prospectus

Emerging Progress of RNA-Based Antitumor Therapeutics

RNA-Based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment

RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise

RNA interference in mammalian and cancer gene therapy

RNA therapeutics in cancer treatment

Nanoparticle‐Mediated Sirna Delivery and Multifunctional Modification Strategies for Effective Cancer Therapy

Antitumor Effect of RNA Interference on Non-Small-cell Lung Cancer in Vivo